A true theranostic approach to medicine: Towards tandem sensor detection and removal of endotoxin in blood

Biosensors and Bioelectronics

Volumn 67, Issue , 2015, Pages 3-10

  Thompson, Michael ^a,b   Blaszykowski, Christophe ^b   Sheikh, Sonia ^a   Romaschin, Alexander ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Econous Systems Inc   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Electromagnetic piezoelectric acoustic sensor (EMPAS); Endotoxemia; Lipopolysaccharide (LPS); Polymyxin B (PMB); Sepsis; Theranostics

Indexed keywords

ACOUSTIC WAVES; ANTIBIOTICS; DIAGNOSIS; PEPTIDES; PIEZOELECTRICITY; PROJECTILES; SUPRAMOLECULAR CHEMISTRY; SURFACE CHEMISTRY; SURFACE TREATMENT;

ENDOTOXEMIA; LIPOPOLYSACCHARIDES; PIEZOELECTRIC ACOUSTIC SENSORS; POLYMYXIN B; SEPSIS; THERANOSTICS;

BLOOD;

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; GLASS; MACROGOL; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE;

ACOUSTICS; ARTICLE; BIOSENSOR; BLOOD; CYTOKINE PRODUCTION; ELECTROMAGNETIC PIEZOELECTRIC ACOUSTIC SENSOR; ENDOTOXEMIA; ENDOTOXIN DETECTION; HUMAN; PIEZOELECTRICITY; SEPSIS; SURFACE PROPERTY; CHEMISTRY; GENETIC PROCEDURES; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PERSONALIZED MEDICINE;

BACTERIA (MICROORGANISMS);

BIOSENSING TECHNIQUES; ENDOTOXINS; HUMANS; INDIVIDUALIZED MEDICINE; LIPOPOLYSACCHARIDES; POLYMYXIN B; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922221601     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.07.008     Document Type: Article

References (51)

1. Ballantyne S.M., Thompson M. Analyst 2004, 129:219-224.
2. Biesta W., van Lagen B., Gevaert V.S., Marcelis A.T.M., Paulusse J.M.J., Nielen M.W.F., Zuilhof H. Chem. Mater. 2012, 24:4311-4318.
3. Binding N., Jaschinski S., Werlich S., Bletz S., Witting U. J. Environ. Monit. 2004, 6:65-70.
4. Crawley N., Thompson M., Romaschin A. Anal. Chem. 2014, 86:130-160.
5. Das A.P., Kumar P.S., Swain S. Biosens. Bioelectron. 2014, 51:62-75.
6. Durán N., Guterres S., Alves O.L. Nanotoxicology-Materials, Methodologies, and Assessments 2014, Springer, New York.
7. Ellis J.S., Thompson M. Phys. Chem. Chem. Phys. 2004, 6:4928-4938.
8. Fedorov K., Blaszykowski C., Sheikh S., Reheman A., Romaschin A., Ni H., Thompson M. Langmuir 2014, 30:3217-3222.
9. Feiler A.A., Sahlholm A., Sandberg T., Caldwell K.D. J. Colloid Interface Sci. 2007, 315:475-481.
10. Fryxell G.E., Rieke P.C., Wood L.L., Engelhard M.H., Williford R.E., Graff G.L., Campbell A.A., Wiacek R.J., Lee L., Halverson A. Langmuir 1996, 12:5064-5075.
11. Funkhouser J. Curr. Drug Discovery 2002, 2:17-19.
12. Garidel P., Brandenburg K. Anti-infect. Agents Med. Chem. 2009, 8:367-385.
13. Guibault G.G., Jordan J.M. CRC Crit. Rev. Anal. Chem. 1988, 19:1-28.
14. Gutsmann T., Schromm A.B., Brandenburg K. Int. J. Med. Microbiol. 2007, 297:341-352.
15. Haglund E., Seale-Goldsmith M.M., Leary J.F. Ann. Biomed. Eng. 2009, 37:2048-2063.
16. Hurley J.C. Clin. Microbiol. Rev. 1995, 8:268-292.
17. Janib S.M., Moses A.S., MacKay J.A. Adv. Drug Deliv. Rev. 2010, 62:1052-1063.
18. Kelkar S.S., Reineke T.M. Bioconjug. Chem. 2011, 22:1879-1903.
19. Latham A.H., Williams M.E. Langmuir 2006, 22:4319-4326.
20. Lee H.-S., Contarino M., Umashankara M., Schön A., Freire E., Smith A.B., Chaiken I.M., Penn L.S. Anal. Bioanal. Chem. 2010, 396:1143-1152.
21. Liu Y., Miyoshi H., Nakamura M. Int. J. Cancer 2010, 120:2527-2537.
22. Malam Y., Loizidou M., Seifalian A.M. Trends Pharmacol. Sci. 2009, 30:592-599.
23. Marshall J.C., Walker P.M., Foster D.M., Harris D., Ribeiro M., Paice J., Romaschin A.D., Derzko A.N. Crit. Care 2002, 6:342-348.
24. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Brit. J. Pharmacol. 2007, 150:552-558.
25. Miele E., Spinelli G.P., Tomao F., Tomao S. Int. J. Nanomed. 2009, 4:99-105.
26. Mitzner S., Schneidewind J., Kalkenhagen D., Loth F., Klinkmann H. Artif. Organs 1993, 17:775-781.
27. Mohorčič M., Jerman I., Zorko M., Butinar L., Orel B., Jerala R., Friedrich J. J. Mater. Sci. Mater. Med. 2010, 21:2775-2782.
28. Mueller M., Lindner B., Kusumoto S., Fukase K., Schromm A.B., Seydel U. J. Biol. Chem. 2004, 279:26307-26313.
29. Munford R.S. Infect. Immun. 2008, 76:454-465.
30. Nahrendorf M., Waterman P., Thurber G., Groves K., Rajopadhye M., Panizzi P., Marinelli B., Aikawa E., Pittet M.J., Swirski F.K., Weissleder R. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1444-1451.
31. Nie S., Xing Y., Kim G.J., Simons J.W. Annu. Rev. Biomed. Eng. 2007, 9:257-288.
32. Ongkudon C.M., Chew J.H., Liu B., Danquah M.K. ISRN Chromatogr. 2012, 2012:649746-1-649746-9.
33. Opal S.M., Scannon P.J., Vincent J.-L., White M., Carroll S.F., Palardy J.E., Parejo N.A., Probble J.P., Lemke J.H. J. Infect. Dis. 1999, 180:1584-1589.
34. Opal S.M. Int. J. Med. Microbiol. 2007, 297:365-377.
35. Pene F., Courtine E., Cariou A., Mira J.P. Crit. Care Med. 2009, 37:S50-S58.
36. Petsch D., Anspach F.B. J. Biotechnol. 2000, 76:97-119.
37. Pujari S.P., Li Y., Regeling R., Zuilhof H. Langmuir 2013, 29:10405-10415.
38. Rao R.K. Endogenous Toxins-Targets for Disease Treatment and Prevention 2010, 1:485-510. Wiley-VCH, Weinheim.
39. Romaschin A.D., Harris D.M., Ribeiro M.B., Paice J., Foster D.M., Walker P.M., Marshall J.C. J. Immunol. Methods 1998, 212:169-185.
40. Ronco C., Piccinni P., Rosner M.H. Endotoxemia and Endotoxin Shock-Disease, Diagnosis and Therapy 2010, Karger, Basel.
41. Seydel U., Schromm A.B., Blunck R., Brandenburg K. CD14 in the Inflammatory Response. Chem. Immunol. 2000, 74:5-24. Karger, Basel.
42. Sheikh S., Sheng J.C.-C., Blaszykowski C., Thompson M. Chem. Sci. 2010, 1:271-275.
43. Sheikh S., Blaszykowski C., Thompson M. Talanta 2011, 85:816-819.
44. Sheikh S., Yang D.Y., Blaszykowski C., Thompson M. Chem. Commun. 2012, 48:1305-1307.
45. Shoji H. Ther. Apher. Dial. 2003, 7:108-114.
46. Thompson M., Ballantyne S.M., Cheran L.-E., Stevenson A.C., Lowe C.R. Analyst 2003, 128:1048-1055.
47. Thompson, M., Sheikh, S., Sheng, J.C.-C., Blaszykowski, C., 2013. United States Patent, US 8,491,958.
48. Tinkle S.S. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2:88-98.
49. Vong T., ter Maat J., van Beek T.A., van Lagen B., Giesbers M., van Hest J.C.M., Zuilhof H. Langmuir 2009, 25:13952-13958.
50. Wang X., Ellis J.S., Lyle E.-L., Sundaram P., Thompson M. Mol. BioSyst. 2006, 2:184-192.
51. Xie J., Lee S., Chen X. Adv. Drug Deliv. Rev. 2010, 62:1064-1079.